/PRNewswire/ NeoDynamics AB (publ) (Nasdaq First North Growth Market Stockholm: NEOD.ST), a medical device company dedicated to advancing the diagnosis and.
/PRNewswire/ Data from the NeoDynamics PULSE study with its biopsy device NeoNavia shows a success rate of 96% in very complex and risky axilla biopsies..
/PRNewswire/ NeoDynamics AB (Spotlight Stock Market: NEOD), a medtech company dedicated to advancing diagnosis and care of breast cancer, will present.
/PRNewswire/ NeoDynamics AB (Spotlight Stock Market: NEOD), a medtech company dedicated to advancing diagnosis and care of breast cancer, will present.